Getting very interesting now that around 20 percent of the raise is now taken up by directors around the 8 cent mark and share price only trading 10-15 percent higher at 15 million market cap with 5 million in cash and a discovery that has produced better results than AGN which NYR does not need to be combined with thrombotic to work
Ann: 2024 EGM Letter to Shareholders and Proxy, page-2
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.013(14.9%) |
Mkt cap ! $20.04M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $267.3K | 2.625M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 170097 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 208703 | 4 |
View Market Depth
| Last trade - 13.51pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |